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Summary. The indices of the functioning of the endothelium in patients with peptic ulcer of the 
stomach and duodenum, combined with diabetes mellitus, have been analyzed and a marked 
vasculoendothelial dysfunction has been established. A correction of the revealed disturbances 
by means of the quinapril has been proposed.
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Introduction. Significant changes of homeostasis 
in diabetes mellitus (DM), including hiperhlikememiya, 
hyperlipidemia directly modulate the expression 
of endothelial receptors in response to numerous 
biologically active compounds. In addition, prolonged 
and excessive influence of metabolic disorders in 
endothelial and smooth muscle cells of blood vessels 
can cause atherogenesis and other morphological 
changes that indirectly affect the release and action 
of endothelin-1 (ET-1) for different target organs [1, 2]. 
Also the role of Helicobacter pylori (Hp) in causing of 
endothelial dysfunction has been shown [3]. But the 
mechanisms of recurrence and progression of PU are 
not found out in the presence of diabetes.
The aim of the study. To investigate the functional 
state of the endothelium in patients with PU, combined 
with DM and to develop improved methods of treatment.
Material and methods. Using a set for definition 
of endothelin-1 (Biomedica, Austria) on immunoassay 
analyzer (ELISA) the level of endothelin-1 (ET-1) 
was found. The concentration of NO metabolites in 
the serum was determined using Gris reagent on 
spectrophotometer SF-46 [4]. The study involved 11 
patients with PU (group I), 11 diabetic patients (group 
II), 30 patients with PU, combined with DM (group III) 
and 8 healthy individuals.
Also, the functional state of endothelium was assessed 
by tests result in reactive hyperemia using blood vessels 
color Doppler of the upper extremity. The study involved 
24 patients with PU, combined with DM (group II), 8 
diabetic patients (group I) and 8 healthy individuals.
Results and discussion. Analysis of the survey results 
showed (table 1), in patients of group I ET-1 levels in 2.6 
times higher, in group II in 3.3 times and in the third 
group in 4.4 times (p<0.05) higher compared with the 
healthy individuals. In group I patients experienced NO 
reduction in 1.14 times, in group II – increased in 1.1 
times and in the third group of patients – increased in 
1.2 times (p<0.05).
It was found after the Doppler study that patients 
with PU, combined with DM and in diabetic patients a 
significant increase of the diameter of blood vessels at 
rest (D0) compared with healthy individuals (p<0,05) 
observed. Despite the larger diameter vessels, blood 
flow velocity did not differ significantly in any of the 
groups (table 2).
Shear stress on the endothelium at rest was high 
in healthy individuals and lower in other groups. In 
response to the test with reactive hyperemia in patients 
with diabetes there was insufficient increase of both 
diameter and shear stress on the endothelium, but the 
tendency to vasodilatation remained.
Sensitivity of the artery to the shear stress (K) in the 
group I was significantly (p<0.05) lower (0.18±0.02), than 
in the group of healthy individuals (0.44±0.13). There 
is a violation of endothelium dependent vasodilatation 
in patients with DM. In the group of patients with PU, 
combined with DM, test with reactive hyperemia caused 
an ambiguous reaction. 
The diameter of the vessels on average has not 
changed, but the percentage observed in three patients 
(18%) complete lack of response in the test (completely 
broken vasoregulation), 6 people (37%) revealed a 
paradoxical reaction (vasoconstriction) and 7 people 
(45%) found positive growth diameter (expected 
vasodilatation). Indicators Δ 1 and K1 in group III is the 
lowest (p<0.05) and make up 12.17±1.85 and 0.11±0.03 
in accordance. Thus, in patients with PU, combined 
with DM expressed abuse of endothelial dependent 
vasodilatation was found.
Analysis of nitroglycerin test showed that diabetic 
patients do not develop violation of the endothelial 
independent vasodilatation, but the response of the 
vessels to the nitrate drug was less than in healthy 
individuals (p<0.05). Namely, 2 reduced in 1.17 times, 
Δ 2 in 2 times, the rate of sensitivity of the artery to the 
shear stress in 3,38 times. In the group of patients with 
PU, combined with DM, expressed abuse of endothelial 
independent vasodilatation was found.
Marked endothelial dysfunction in patients with PU, 
combined with DM, which manifested by increased 
levels of ET-1 and NO in the blood, as well as violation 
of endothelial dependent vasodilatation and endothelial 
independent vasodilatation was established. Probably 
pathogenetic links of the detected violations are HP 
persistence and performance of high concentration of 
glucose in tissue. High concentrations of NO in plasma 
of patients with PU, combined with DM, do not cause 
vasodilatation, but rather leads to vasoconstriction in 
37% of subjects. Taking into account the results of tests 
with nitroglycerin, we can provide specific violation of 
endothelial independent vasodilatation in these patients, 
including disorders due to the receptor system.
In view of the foregoing, the third group was 
divided into 2 groups: control (Ia) and primary (Ib). To 
correct the detected changes, with the basic treatment 
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Table 1
Indicators of endothelin-1 and NO in patients with peptic ulcer, combined with diabetes mellitus, 
during the exacerbation (M ± m)
Data Healthy individuals n=8
Group І
n=11
Group ІІ
n=11
Group ІІІ
n=30
ЕТ-1, fmol/ml 0.38±0.06 0.98±0.08* 1.26±0.07*/** 1.66±0.09*/**/***
NO,  mmol/l 19.05±0.77 16.67±0.76* 21.15±0.55*/** 22.87±0.42*/**/***
         
Note: * Significant changes compared to the data of the healthy individuals (p<0.05); ** Significant changes compared 
to the data of patients with PU (p<0.05); *** Significant changes compared with the data of the diabetic patients 
(p<0.05).
Table 2
Indicators of the brachial artery sensitivity to the shear stress on the endothelium in patients with peptic 
ulcer, combined with diabetes mellitus, during the exacerbation (M ± m)
Data Healthy individuals n=8 Group І   n=8 Group ІІ     n=16
D0, sm 0.33±0.02 0.39±0.01* 0.41±0.01*
V0 84.63±1.70 83.13±2.43 82.62±2.48
τ0 din/sm2 52.30±2.47 43.20±2.21* 40.61±1.72*
D1, sm 0.38±0.02 0.41±0.02 0.42±0.02
V1 134.63±2.58 123.63±4.41 112.63±3.24*
1 din/sm2 72.46±2.93 61.36±3.01* 52.79±2.11*/**
Δ 1 20.16±1.45 16.15±1.76 12.17±1.85*/**
К1 0.44±0.13 0.18±0.02* 0.11±0.03*/**
Vasodilatation, % 14.78±2.51 6.36±0.49* 0.90±0.37*/**
D2, sm 0.42±0.02 0.46±0.02 0.45±0.02
V2 136.25±2.88 123.13±2.84* 104.19±4.79*/**
2 din/sm2 65.07±2.40 53.77±2.69* 45.97±2.34*/**
Δ 2 12.77±0.88 10.57±1.46 5.35±1.33*/**
К2 1.29±0.22 0.98±0.23 0.29±0.07*/**
Vasodilatation, % 29.26±2.96 20.17±2.08* 9.39±3.37*/**
         
Note: * Significant changes compared to the data of the healthy individuals (p<0.05); ** Significant changes compared 
with the data of the diabetic patients (p<0.05).
(rabeprazole – 20 mg twice daily, amoxicillin – 1000 mg 
twice daily, clarithromycin – 500 mg twice daily for 14 
days) for patients of the primary group quinapril drug at 
a dose of 2.5 mg 1 time per day in the morning under 
the control of hemodynamic parameters within a week, 
with the transition to 5 mg once daily in the morning for 
three weeks. Repeated studies conducted 4-6 weeks 
after treatment.
Analyzing the data of the functional state of the 
endothelium in patients with PU, combined with DM 
(table 3), it was found that the level of ET-1 decreased 
slightly in case of the basic treatment (36%), but the 
highest reduction observed in the group of patients who 
received quinapril (in 3.2 times). 
Table 3
Indicators of endothelin-1 and NO in patients with peptic ulcer, combined with diabetes mellitus, dynamics 
of treatment (M ± m)
Data Healthy individuals n=8
Group Іa
n=10
Group Іb
n=10
Before treatment After treatment Before treatment After treatment
ЕТ-1, fmol/ml 0.38±0.06 1.52±0.08 1.12±0.07*/** 1.64±0.11 0.51±0.05**/***
NO, mmol/l 19.05±0.77 23.01±0.34 21.64±0.52*/** 22.98±0.42 20.01±0.21**/***
      
Note. * Significant changes compared to the data of the healthy individuals (p<0.05); ** Significant changes compared 
with the data in the subgroup before and after treatment (p<0.05); *** Significant changes compared with the data in 
the subgroup Ia after treatment (p<0.05).
165
THE EUROPEAN ASSOCIATION OF PEDAGOGUES AND PSYCHOLOGISTS “SCIENCE”
After the treatment, the results tend to set Doppler 
reducing of the diameter of blood vessels in the group 
Ib (0.40±0.02) and diameter unchanged in group Ia 
(0.41±0.02). According to the literature, and ACE-
causing effect on the diameter of the vessel can be 
found after combined treatment duration of 6 months. 
Also the tendency to improve blood flow velocity at 
rest (3%) and shear stress at rest (8%) was showed. 
However a significant increase in the rate of 11% and 
the shear stress in response to reactive hyperemia test 
with 13% compared with before treatment revealed 
(p<0.05). Patients who received basic treatment had no 
significant differences in data.
These changes were confirmed by sensitivity index 
of brachial artery to the shear stress which in the patients 
of group Ib increased by 58%, and vasodilatation, which 
increased by 6%.
Conclusions:
1. The disease HP-associated peptic ulcer of 
the stomach and duodenum, combined with diabetes 
mellitus, is characterized by marked vascular endothelial 
dysfunction.
2. Application of quinapril with basic therapy 
results in significant positive indicators of endothelial 
function, namely the reduction of endothelin-1 levels 
and NO, which is also confirmed by the shear stress 
changes and sensitivity of the brachial artery to the 
shear stress during reactive hyperemia tests.
Prospects for further research. It is advisable to 
study the impact of the proposed treatment on the other 
pathogenic links in case of peptic ulcer of the stomach 
and duodenum, combined with diabetes mellitus.
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